Your browser doesn't support javascript.
loading
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial.
Mukherjee, Somnath; Hurt, Christopher N; Adams, Richard; Bateman, Andrew; Bradley, Kevin M; Bridges, Sarah; Falk, Stephen; Griffiths, Gareth; Gwynne, Sarah; Jones, Christopher M; Markham, Philip J; Maughan, Tim; Nixon, Lisette S; Radhakrishna, Ganesh; Roy, Rajarshi; Schoenbuchner, Simon; Sheikh, Hamid; Spezi, Emiliano; Hawkins, Maria; Crosby, Thomas D L.
Afiliação
  • Mukherjee S; Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Hurt CN; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Adams R; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Bateman A; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Bradley KM; University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Bridges S; Wales Research and Diagnostic Positron Emission Tomography Centre (PETIC), Cardiff University, Cardiff, UK.
  • Falk S; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Griffiths G; University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Gwynne S; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Jones CM; South West Wales Cancer Centre, Swansea Bay University Health Board, Swansea, UK.
  • Markham PJ; Department of Oncology, University of Cambridge, Cambridge, UK.
  • Maughan T; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Nixon LS; Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
  • Radhakrishna G; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Roy R; The Christie Hospital, The Christie Hospitals NHS Foundation Trust, Manchester, UK.
  • Schoenbuchner S; Queen's Centre for Oncology, Hull University Teaching Hospitals NHS Trust, UK.
  • Sheikh H; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Spezi E; The Christie Hospital, The Christie Hospitals NHS Foundation Trust, Manchester, UK.
  • Hawkins M; School of Engineering, Cardiff University, Cardiff, UK.
  • Crosby TDL; Department of Medical Physics & Biomedical Engineering, University College London, London, UK.
EClinicalMedicine ; 61: 102059, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37409323
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: EClinicalMedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: EClinicalMedicine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido